Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1991 1
2002 3
2005 1
2006 2
2007 1
2008 3
2009 2
2010 3
2011 1
2012 1
2013 2
2014 1
2018 1
2019 1
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.
Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY, Fitzpatrick LA, Mitlak B, Papapoulos S, Rizzoli R, Dore RK, Bilezikian JP, Saag KG. Bone HG, et al. Among authors: dore rk. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2949-2957. doi: 10.1210/jc.2018-00163. J Clin Endocrinol Metab. 2018. PMID: 29800372 Free PMC article. Clinical Trial.
The gout diagnosis.
Dore RK. Dore RK. Cleve Clin J Med. 2008 Jul;75 Suppl 5:S17-21. doi: 10.3949/ccjm.75.suppl_5.s17. Cleve Clin J Med. 2008. PMID: 18822471 Free article. Review.
The RANKL pathway and denosumab.
Dore RK. Dore RK. Rheum Dis Clin North Am. 2011 Aug;37(3):433-52, vi-vii. doi: 10.1016/j.rdc.2011.07.004. Rheum Dis Clin North Am. 2011. PMID: 22023901 Review.
24 results